TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oral Transmucosal Drugs
1.2 Key Market Segments
1.2.1 Oral Transmucosal Drugs Segment by Type
1.2.2 Oral Transmucosal Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oral Transmucosal Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Oral Transmucosal Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oral Transmucosal Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Transmucosal Drugs Market Competitive Landscape
3.1 Global Oral Transmucosal Drugs Sales by Manufacturers (2019-2024)
3.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oral Transmucosal Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Transmucosal Drugs Sales Sites, Area Served, Product Type
3.6 Oral Transmucosal Drugs Market Competitive Situation and Trends
3.6.1 Oral Transmucosal Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Transmucosal Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oral Transmucosal Drugs Industry Chain Analysis
4.1 Oral Transmucosal Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oral Transmucosal Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oral Transmucosal Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Transmucosal Drugs Sales Market Share by Type (2019-2024)
6.3 Global Oral Transmucosal Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Oral Transmucosal Drugs Price by Type (2019-2024)
7 Oral Transmucosal Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Transmucosal Drugs Market Sales by Application (2019-2024)
7.3 Global Oral Transmucosal Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Transmucosal Drugs Sales Growth Rate by Application (2019-2024)
8 Oral Transmucosal Drugs Market Segmentation by Region
8.1 Global Oral Transmucosal Drugs Sales by Region
8.1.1 Global Oral Transmucosal Drugs Sales by Region
8.1.2 Global Oral Transmucosal Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Oral Transmucosal Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oral Transmucosal Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Transmucosal Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oral Transmucosal Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oral Transmucosal Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 LTS Lohmann Therapie-Systeme AG
9.1.1 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Basic Information
9.1.2 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Overview
9.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Market Performance
9.1.4 LTS Lohmann Therapie-Systeme AG Business Overview
9.1.5 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs SWOT Analysis
9.1.6 LTS Lohmann Therapie-Systeme AG Recent Developments
9.2 Soligenix
9.2.1 Soligenix Oral Transmucosal Drugs Basic Information
9.2.2 Soligenix Oral Transmucosal Drugs Product Overview
9.2.3 Soligenix Oral Transmucosal Drugs Product Market Performance
9.2.4 Soligenix Business Overview
9.2.5 Soligenix Oral Transmucosal Drugs SWOT Analysis
9.2.6 Soligenix Recent Developments
9.3 ZIM Laboratories Limited
9.3.1 ZIM Laboratories Limited Oral Transmucosal Drugs Basic Information
9.3.2 ZIM Laboratories Limited Oral Transmucosal Drugs Product Overview
9.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Product Market Performance
9.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs SWOT Analysis
9.3.5 ZIM Laboratories Limited Business Overview
9.3.6 ZIM Laboratories Limited Recent Developments
9.4 Access Pharmaceutical Inc.
9.4.1 Access Pharmaceutical Inc. Oral Transmucosal Drugs Basic Information
9.4.2 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Overview
9.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Market Performance
9.4.4 Access Pharmaceutical Inc. Business Overview
9.4.5 Access Pharmaceutical Inc. Recent Developments
9.5 C.L Pharm
9.5.1 C.L Pharm Oral Transmucosal Drugs Basic Information
9.5.2 C.L Pharm Oral Transmucosal Drugs Product Overview
9.5.3 C.L Pharm Oral Transmucosal Drugs Product Market Performance
9.5.4 C.L Pharm Business Overview
9.5.5 C.L Pharm Recent Developments
9.6 Cure Pharmaceutical
9.6.1 Cure Pharmaceutical Oral Transmucosal Drugs Basic Information
9.6.2 Cure Pharmaceutical Oral Transmucosal Drugs Product Overview
9.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Product Market Performance
9.6.4 Cure Pharmaceutical Business Overview
9.6.5 Cure Pharmaceutical Recent Developments
9.7 Aquestive Therapeutics, Inc.
9.7.1 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Basic Information
9.7.2 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Overview
9.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Market Performance
9.7.4 Aquestive Therapeutics, Inc. Business Overview
9.7.5 Aquestive Therapeutics, Inc. Recent Developments
9.8 NAL Pharma
9.8.1 NAL Pharma Oral Transmucosal Drugs Basic Information
9.8.2 NAL Pharma Oral Transmucosal Drugs Product Overview
9.8.3 NAL Pharma Oral Transmucosal Drugs Product Market Performance
9.8.4 NAL Pharma Business Overview
9.8.5 NAL Pharma Recent Developments
9.9 IntelGenx Corp.
9.9.1 IntelGenx Corp. Oral Transmucosal Drugs Basic Information
9.9.2 IntelGenx Corp. Oral Transmucosal Drugs Product Overview
9.9.3 IntelGenx Corp. Oral Transmucosal Drugs Product Market Performance
9.9.4 IntelGenx Corp. Business Overview
9.9.5 IntelGenx Corp. Recent Developments
9.10 Eisai Co., Ltd.
9.10.1 Eisai Co., Ltd. Oral Transmucosal Drugs Basic Information
9.10.2 Eisai Co., Ltd. Oral Transmucosal Drugs Product Overview
9.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Product Market Performance
9.10.4 Eisai Co., Ltd. Business Overview
9.10.5 Eisai Co., Ltd. Recent Developments
9.11 Otsuka Pharmaceutical Co., Ltd.
9.11.1 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Basic Information
9.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Overview
9.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Market Performance
9.11.4 Otsuka Pharmaceutical Co., Ltd. Business Overview
9.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
9.12 Teva Pharmaceutical Industries Ltd.
9.12.1 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Basic Information
9.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Overview
9.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Market Performance
9.12.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.13 GlaxoSmithKline plc
9.13.1 GlaxoSmithKline plc Oral Transmucosal Drugs Basic Information
9.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Product Overview
9.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Product Market Performance
9.13.4 GlaxoSmithKline plc Business Overview
9.13.5 GlaxoSmithKline plc Recent Developments
9.14 Viatris
9.14.1 Viatris Oral Transmucosal Drugs Basic Information
9.14.2 Viatris Oral Transmucosal Drugs Product Overview
9.14.3 Viatris Oral Transmucosal Drugs Product Market Performance
9.14.4 Viatris Business Overview
9.14.5 Viatris Recent Developments
9.15 Bristol-Myers Squibb Company
9.15.1 Bristol-Myers Squibb Company Oral Transmucosal Drugs Basic Information
9.15.2 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Overview
9.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Market Performance
9.15.4 Bristol-Myers Squibb Company Business Overview
9.15.5 Bristol-Myers Squibb Company Recent Developments
10 Oral Transmucosal Drugs Market Forecast by Region
10.1 Global Oral Transmucosal Drugs Market Size Forecast
10.2 Global Oral Transmucosal Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Transmucosal Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Oral Transmucosal Drugs Market Size Forecast by Region
10.2.4 South America Oral Transmucosal Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oral Transmucosal Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oral Transmucosal Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oral Transmucosal Drugs by Type (2025-2030)
11.1.2 Global Oral Transmucosal Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oral Transmucosal Drugs by Type (2025-2030)
11.2 Global Oral Transmucosal Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Oral Transmucosal Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Oral Transmucosal Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings